Search Results

The KRONUS TRAb ELISA Assay Kit is for the semi-quantitative determination of antibodies to the thyroid stimulating hormone receptor in human serum. The KRONUS TRAb ELISA Assay is useful as an aid in the diagnosis of Graves' Disease in conjunction with other clinical and laboratory findings.

Not Found

The provided text is a 510(k) premarket notification letter from the FDA regarding the KRONUS TSH Receptor Autoantibody (TRAb) ELISA Kit. This document primarily focuses on the regulatory approval and substantial equivalence determination for an in vitro diagnostic (IVD) device, specifically an ELISA assay.

Therefore, the information typically requested for AI/ML device studies (such as acceptance criteria, sample sizes for test/training sets, expert ground truth, adjudication methods, MRMC studies, and standalone performance) is not available in these types of regulatory documents for IVD kits. These documents do not contain the detailed study protocols or results that would describe the performance against specific acceptance criteria for AI algorithms.

Based on the provided text, I cannot describe the acceptance criteria and the study that proves the device meets them in the format requested, as the information is not present in this regulatory letter.

This document confirms the device's classification and substantial equivalence to a predicate device, but it does not detail the specific performance studies and criteria that would be found in a clinical study report or a more technical submission for an AI/ML device.

Ask a specific question about this device